ARCA biopharma (ORKA) Free Cash Flow (2003 - 2026)
ARCA biopharma (ORKA) free cash flow from Dec 31, 2003 to Mar 31, 2026. The TTM ARCA biopharma (ORKA) free cash flow is -$91M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
ARCA biopharma (ORKA) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +13.27% |
| 3 Years | +145.93% |
| 5 Years | +35.23% |
| 10 Years | -14.12% |
| All Time | -6.10% |
Annual Free Cash Flow change of ARCA biopharma (ORKA)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$24M | -73.25% |
| 2025 | -$88M | +52.37% |
| 2024 | -$58M | +1058.28% |
| 2023 | -$5.01M | -54.08% |
| 2022 | -$11M | -41.97% |
| 2021 | -$19M | +142.89% |
| 2020 | -$7.74M | +61.25% |
| 2019 | -$4.80M | -41.75% |
| 2018 | -$8.24M | -92.39% |
| 2014 | -$108M | +1404.31% |
| 2013 | -$7.20M | -92.75% |
| 2012 | -$99M | +4.28% |
| 2011 | -$95M | +1044.47% |
| 2010 | -$8.32M | -91.33% |
| 2003 | -$96M | N/A |
Comparison ARCA biopharma (ORKA) five years free cash flow CAGR with competitors
ARCA biopharma (ORKA) five years free cash flow CAGR is 51.87%.